RecruitingNot ApplicableNCT06931665

Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State

Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State: a Randomized, Controlled Cross-over Study


Sponsor

University of Basel

Enrollment

26 participants

Start Date

Jul 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to explore the impact of Animal Assisted Therapy (AAT) on brain signal complexity in patients with minimally conscious state (MCS) by analyzing electroencephalogram (EEG) entropy. MCS patients typically exhibit reduced brain entropy compared to healthy individuals, indicating lower brain complexity. The study will assess whether AAT can enhance this complexity, which is crucial for understanding consciousness levels. Entropy, a measure of randomness in brain activity, will be used to evaluate AAT's effectiveness. In addition, electrocardiography (ECG), electrodermal activity (EDA) and behavioral measurements will also be collected.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Inpatients in one of the study sites
  • Acquired brain injury resulting from either traumatic or non-traumatic events
  • Diagnosis of MCS defined by CRS-R according to the Aspen criteria (Giacino, 2005)
  • Informed consent as documented by signature by the patient's legal representative
  • Physiologically stable
  • Aged 18 or over

Exclusion Criteria3

  • Phobia or allergies to any of the involved animals
  • Medical contraindications: acute or chronic disease (e.g. chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes)
  • Radical changes in medication (decision made with responsible physician)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAnimal Assisted Occupational Therapy

AAT is an ergotherapy including an animal. AAT is a specific type of Animal Assisted Intervention (AAI) with a therapeutic aim.


Locations(2)

REHAB Basel

Basel, Switzerland

Service de Neurorééducation, Hopitaux Universitaires Genevois

Geneva, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06931665


Related Trials